60 results
8-K
EX-10.1
CYCC
Cyclacel Pharmaceuticals Inc
2 May 24
Cyclacel Pharmaceuticals ANNOUNCES $8.0 MILLION PRIVATE PLACEMENT
5:00pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
of the product;
we may decide to recall such product candidates from the marketplace after they are approved;
we could be sued and held liable … to cease distribution or to recall batches of our product candidates; and
in the event of approval to market and commercialize a product candidate
8-K
EX-10.2
4vj 590hvl
26 Dec 23
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
9:29am
8-K
EX-1.1
43d4rn9tl42
15 Mar 21
Cyclacel Pharmaceuticals Prices $12.65 Million
5:21pm
8-K
EX-10.1
4nrkspfea 5t
22 Dec 20
Cyclacel Pharmaceuticals ANNOUNCES At-the-market $7 MILLION strategic INVESTMENT BY FUNDAMENTAL INVESTOR ACORN BIOVENTURES
4:05pm
8-K
EX-1.2
lz9 ko7tw
24 Apr 20
Cyclacel Announces PRICING OF $20 MILLION PUBLIC OFFERING
4:38pm
8-K
EX-1.1
0zcog4ptpoh2nt
21 Jul 17
Cyclacel Announces Closing of $15.2 Million Underwritten Public Offering
12:00am